Journal article
Molecular-Signaling Pathways of Ginsenosides Rb in Myocardial Ischemia-Reperfusion Injury: A Mini Review
- Abstract:
- Reperfusion injury following myocardial ischemia remained a challenge for optimal treatment of myocardial infarction. Ginsenosides Rb (G-Rb), the primary components of ginsenoside, have been reported to exert cardioprotective effects via numerous mechanisms. G-Rb1 mediate cardioprotective effects via various signaling pathways, including mitochondrial apoptotic pathway, PI3K/Akt/mTOR, HIF-1α and GRF91, RhoA, p38α MAPK, and eNOS. G-Rb2 activates the SIRT-1 pathway, while G-Rb3 promotes both JNK-mediated NF-κB and PERK/Nrf2/HMOX1. Generally, ginsenosides Rb1, 2, and 3 modulates oxidative stress, inflammation, and apoptosis, contributing to the improvement of structural, functional and biochemical parameters. In conclusion, G-Rb, particularly G-Rb1, have vast potential as a supplement in attenuating reperfusion injury. Translation into a clinical trial is warranted to confirm the beneficial effects of G-Rb.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.2MB, Terms of use)
-
- Publisher copy:
- 10.7150/ijms.64984
Authors
- Publisher:
- Ivyspring International Publisher
- Journal:
- International Journal of Medical Sciences More from this journal
- Volume:
- 19
- Issue:
- 1
- Pages:
- 65-73
- Publication date:
- 2021-12-15
- DOI:
- EISSN:
-
1449-1907
- ISSN:
-
1449-1907
- Language:
-
English
- Keywords:
-
- Pubs id:
-
1251529
- Local pid:
-
pubs:1251529
- Source identifiers:
-
W4200360703
- Deposit date:
-
2026-04-23
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2021
If you are the owner of this record, you can report an update to it here: Report update to this record